AXGT

Axovant Gene Therapies (AXGT)

Axovant Gene Therapies Ltd

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:AXGT

1 2 3 4 5 6 7 8 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2023/04/26	05:05	Edgar (US Regulatory)	Termination of Registration of a Class of Security Under Section 12(g) (15-12g)	NASDAQ:AXGT	Axovant Gene Therapies Ltd
2023/04/18	05:17	Edgar (US Regulatory)	Post-effective Amendment to Registration Statement (pos Am)	NASDAQ:AXGT	Axovant Gene Therapies Ltd
2023/04/18	05:14	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:AXGT	Axovant Gene Therapies Ltd
2023/04/12	21:52	Edgar (US Regulatory)	Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)	NASDAQ:AXGT	Axovant Gene Therapies Ltd
2023/04/07	05:08	Edgar (US Regulatory)	Notification Filed by a National Securities Exchange to Report the Removal From Listing and Registration of Matured , Redeemed or Retired Securities (25)	NASDAQ:AXGT	Axovant Gene Therapies Ltd
2023/04/07	05:07	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:AXGT	Axovant Gene Therapies Ltd
2023/03/17	19:03	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	NASDAQ:AXGT	Axovant Gene Therapies Ltd
2023/03/16	05:26	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:AXGT	Axovant Gene Therapies Ltd
2023/02/22	06:06	Edgar (US Regulatory)	Proxy Statement - Merger or Acquisition (definitive) (defm14a)	NASDAQ:AXGT	Axovant Gene Therapies Ltd
2023/02/14	21:04	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	NASDAQ:AXGT	Axovant Gene Therapies Ltd
2023/02/14	21:02	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:AXGT	Axovant Gene Therapies Ltd
2023/02/14	20:47	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:AXGT	Axovant Gene Therapies Ltd
2023/02/13	22:53	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:AXGT	Axovant Gene Therapies Ltd
2023/02/11	06:01	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:AXGT	Axovant Gene Therapies Ltd
2023/02/09	20:01	Edgar (US Regulatory)	Proxy Statement - Merger or Acquisition (preliminary) (prem14a)	NASDAQ:AXGT	Axovant Gene Therapies Ltd
2022/12/15	06:11	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	NASDAQ:AXGT	Axovant Gene Therapies Ltd
2022/12/15	06:05	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:AXGT	Axovant Gene Therapies Ltd
2022/11/10	21:04	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:AXGT	Axovant Gene Therapies Ltd
2022/11/10	21:03	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:AXGT	Axovant Gene Therapies Ltd
2022/09/15	05:09	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:AXGT	Axovant Gene Therapies Ltd
2022/08/11	20:04	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:AXGT	Axovant Gene Therapies Ltd
2022/06/14	20:02	Edgar (US Regulatory)	Annual Report (10-k)	NASDAQ:AXGT	Axovant Gene Therapies Ltd
2022/02/15	03:58	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:AXGT	Axovant Gene Therapies Ltd
2022/02/11	21:03	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:AXGT	Axovant Gene Therapies Ltd
2022/02/11	21:01	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:AXGT	Axovant Gene Therapies Ltd
2022/02/11	07:08	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:AXGT	Axovant Gene Therapies Ltd
2022/02/09	21:01	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:AXGT	Axovant Gene Therapies Ltd
2022/01/26	06:51	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:AXGT	Axovant Gene Therapies Ltd
2021/12/10	08:32	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:AXGT	Axovant Gene Therapies Ltd
2021/12/10	08:31	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:AXGT	Axovant Gene Therapies Ltd